Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1995 1
2004 2
2006 2
2009 1
2012 1
2013 3
2014 3
2016 1
2020 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Bladder squamous cell carcinoma.
Wong JT, Wasserman NF, Padurean AM. Wong JT, et al. Radiographics. 2004 May-Jun;24(3):855-60. doi: 10.1148/rg.243035153. Radiographics. 2004. PMID: 15143234 Review. No abstract available.
Programmed Cell Death-Ligand-1 expression in Bladder Schistosomal Squamous Cell Carcinoma - There's room for Immune Checkpoint Blockage?.
Madureira AC. Madureira AC. Front Immunol. 2022 Sep 2;13:955000. doi: 10.3389/fimmu.2022.955000. eCollection 2022. Front Immunol. 2022. PMID: 36148227 Free PMC article. Review.
Schistosoma haematobium, the causative agent of urogenital schistosomiasis, is a carcinogen type 1 since 1994. It is strongly associated with bladder squamous-cell carcinoma in endemic regions, where it accounts for 53-69% of bladder-carcinoma cases. . …
Schistosoma haematobium, the causative agent of urogenital schistosomiasis, is a carcinogen type 1 since 1994. It is strongly associated wit …
Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma.
Rausch S, Lotan Y, Youssef RF. Rausch S, et al. Urol Oncol. 2014 Jan;32(1):32.e11-6. doi: 10.1016/j.urolonc.2012.11.020. Epub 2013 Feb 20. Urol Oncol. 2014. PMID: 23433891 Review.
Bladder squamous cell carcinoma, squamous metaplasia, and transitional cell carcinoma with squamous differentiation are infrequent findings in Western countries. ...Our review summarizes the available data on clinical presentation, treatment, and outco …
Bladder squamous cell carcinoma, squamous metaplasia, and transitional cell carcinoma with squamous differentiat …
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
Necchi A, Madison R, Raggi D, Jacob JM, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Huang R, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Alexander BM, Grivas P, Ross JS. Necchi A, et al. Eur Urol. 2020 Apr;77(4):548-556. doi: 10.1016/j.eururo.2020.01.003. Epub 2020 Jan 17. Eur Urol. 2020. PMID: 31959546
Bladder squamous cell carcinoma in situ in the background of condyloma acuminatum in a kidney transplant recipient.
Yan CL, Gallo RA, Pandiri M, Gallo SJ. Yan CL, et al. Can J Urol. 2023 Apr;30(2):11505-11508. Can J Urol. 2023. PMID: 37074751
Condyloma acuminatum with synchronous squamous cell carcinoma in situ (CIS) rarely occurs in the bladder. In developed countries, bladder squamous cell carcinoma (SCC) is uncommon. Among the various noninvasive squamous bladder lesions, there is signif …
Condyloma acuminatum with synchronous squamous cell carcinoma in situ (CIS) rarely occurs in the bladder. In developed countries, bladder …
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.
Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Bivalacqua TJ, Kinzler K, Vogelstein B, Netto GJ, Papadopoulos N. Cowan M, et al. Mod Pathol. 2016 May;29(5):511-5. doi: 10.1038/modpathol.2016.53. Epub 2016 Mar 11. Mod Pathol. 2016. PMID: 26965579 Free PMC article.
TERT promoter mutations, commonly found in conventional urothelial carcinoma, are also highly prevalent in urinary bladder squamous cell carcinoma suggesting a common tumorigenesis and potential utility as a molecular urine-based-screening assay....
TERT promoter mutations, commonly found in conventional urothelial carcinoma, are also highly prevalent in urinary bladder squamou …
Small cell carcinoma of the bladder associated with schistosomiasis: a case report.
Almeida M, Canas-Marques R, Lopez-Beltran A, Rebola J, Lúcio R, Montironi R, Cheng L, Fonseca J. Almeida M, et al. Anal Quant Cytopathol Histpathol. 2014 Dec;36(6):339-44. Anal Quant Cytopathol Histpathol. 2014. PMID: 25803993
In Africa and the Middle East, with highly prevalent chronic infection by Schistosoma haematobium (S. haematobium), urinary bladder squamous cell carcinoma is the most prevalent histologic type of bladder cancer, followed by transitional cell carcinoma …
In Africa and the Middle East, with highly prevalent chronic infection by Schistosoma haematobium (S. haematobium), urinary bladder …
Novel markers of squamous differentiation in the urinary bladder.
Huang W, Williamson SR, Rao Q, Lopez-Beltran A, Montironi R, Eble JN, Grignon DJ, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Hahn NM, Wang M, Koch MO, Cheng L. Huang W, et al. Hum Pathol. 2013 Oct;44(10):1989-97. doi: 10.1016/j.humpath.2013.04.005. Epub 2013 Jun 24. Hum Pathol. 2013. PMID: 23806524
Urinary bladder squamous cell carcinoma and urothelial carcinoma with squamous differentiation are often high-grade and high-stage tumors that are thought to be associated with a poorer prognosis and response to therapy compared with urothelial carcino …
Urinary bladder squamous cell carcinoma and urothelial carcinoma with squamous differentiation are often high-gr …
19 results